🚨paper alert 💥Our P-MAPS follow-up in @Gut_BMJ 🔑 Points -15🇪🇺centers -⏰3y follow-up -Early 🦠 in AP predicts post🏥 mortality and diabetes🍬 @albrechtneesse @emadelomar #PMAPS #pancreas #microbiome

#RadekKroupa #MichaelHirth @PatrickMichl1 #PeterHegyi #StevenPhilcox #MarcoBruno #AndrewMetz

Our 🌍 follow-up Trial 👉P-MAPS II is recruiting passing the number of💥430! Patients with AP. 🏁 Is 700 patients! 👍Stay tuned 🙏Deeply grateful for the old and new P-MAPS friends @DeMadaria @Lguilabert1 @SN_gastro @DharJahnvi @Samanta_JayPGI @sanjay_HPB @LumirKunovsky

#SilkeCameron #YanaKocheva #AlbrechtHoffmeister #ChristianMeinhardt @ArltAlexander #LukaszNawacki #ArpadPanyko #VitorNunes #MariaLourdesRuizRebollo #CesareoPardo #VeitPhillip #AldisPukitis #DianaVaselane #EcaterinaRinija #ArlettSchäfer #JulianSeelig #VolkerEllenrieder

Huge thanks to our young researchers @richmei2001 @rahelshuu @jacobhammx And of course that wont happen without the strong and brilliant P-MAPS consortium @lelecapurso @SandruVasile @SimonSirtl #KaiAntweiler #ThomasAsendorf @DammMarko #LinhDang #FabianFrost

@EKFStiftung My team and I would like to thank @EKFStiftung for their tremendous support over the next 3 years. The 2-tiered evaluation process of our proposal was very speedy which is crucial in these highly competitive fields such as microbiome research 🙏🙏 @AmmerHerrmenau

Acute pancreatitis is life-threatening—and there is currently no treatment available. A global study is examining the gut microbiome of 700 patients. @albrechtneesse and his team aim to identify biomarkers and new therapeutic approaches. https://t.co/l5gqxz0dXb

So proud that our latest DRACULA trial is now online! 🦇🙌 ✅ 585 patients, 29 centers, with percutaneous drainage in necrotizing pancreatitis https://t.co/kD9A5RCBfY #pancreatitis #LMU #myUEG

Excited to see this one out 💪🏻 Glad to have contributed together with @AmmerHerrmenau

If you love pancreatology and want to grow in this field, this is your course ⬇️⬇️⬇️

Pancreatology is on 🔥at @my_ueg, Great sessions all around🙌🏼

Always great to share a session at @my_ueg with your pancreas friends and of course, mentor💜 @DeMadaria @AmmerHerrmenau @YouppiePancreas

1/3 Guys, if you are in Berlin in the #UEGweek @my_ueg, we invite you to attend on Monday 10am Room A4 the session "From The Lion King to Waterland: A journey through pancreatitis" We will show the final results of the #WATERLANDtrial, largest RCT in pancreatitis ever

Stay tuned! October 6th at @my_ueg We will present results from WATERLAND trial @DeMadaria 🦁🦩

Lucía Guilabert is addressing a controversial topic! Acute pancreatitis and anticoagulation #HarvardPancreas2025

📢 Join us for Pancreas 2025 – Annual Meeting of the Indian Pancreas Club ✨ Search · Innovate · Heal 📅 Sept 4–6, 2025 📍 Christian Medical College Vellore, India 🌐 Register & view full program: https://t.co/8X8AO0KZ1M #Pancreas2025 #MedTwitter #MedEd #GastroTwitter

🌟Know Your Speaker at #Pancreas2025 🌟 Dr. Albrecht Neesse 🇩🇪, Keynote Speaker. 📅 Sept 4–6, 2025 | Annual Conference of the Indian Pancreas Club 📍 Vellore, India 🔗 Register & view schedule: https://t.co/QIFlM8khQH

✅Small & stable #PancreaticCysts may not require ongoing #surveillance In the #PACYFIC trial, cysts <15 mm & slow-growing (<2.5 mm/year) showed very low risk of malignancy — comparable to the general population 📖 #OpenAccess 👉 https://t.co/3auZ6Zd2Jm @my_ueg

@endoscopyjrnl Interesting study! The use of PPIs in conjunction with LAMS-treated pancreatic necrosis is a crucial topic. I'd like to know if the study delves into how the timing and dosage of PPI administration might impact patient outcomes. Did they find any significant variations in

Investigating PPI use and outcomes in LAMS-treated pancreatic necrosis Find the article at: https://t.co/FaNSE1TMLs Jacob Hamm et al.